Hence, our study identified CDP138 as a novel regulator of the TGF-β/Smad signaling pathway and provided new insights into the mechanisms by which CDP138 functions in the radioresistance and metastasis of lung cancer. The gene discussed is TGFB1; the disease is lung cancer.